Assessment of recombinant factor VIIa as an antidote for bleeding induced in the rabbit by low molecular weight heparin

This publication has 16 references indexed in Scilit:

• Recombinant factor VIIa (NovoSeven®) restores deficient coagulation: Experience from an ex vivo model
  Seminars in Hematology, 2001
• Recombinant Activated Factor VII (rFVIIa): Characterization, Manufacturing, and Clinical Development
  Seminars in Thrombosis and Hemostasis, 2001
• Ability of Recombinant Factor VIIa to Generate Thrombin During Inhibition of Tissue Factor in Human Subjects
  Circulation, 2001
• REDUCED TRANSFUSION REQUIREMENTS BY RECOMBINANT FACTOR VIIa IN ORTHOTOPIC LIVER TRANSPLANTATION
  Transplantation, 2001
• Comparison of the Bleeding Potential of Vampire Bat Salivary Plasminogen Activator Versus Tissue Plasminogen Activator in an Experimental Rabbit Model
  Circulation, 1995
• Pharmacokinetics and pharmacodynamics of recombinant factor VIIa
  Clinical Pharmacology & Therapeutics, 1994
• An animal model of fibrinolytic bleeding based on the rebleed phenomenon: Application to a study of vulnerability of hemostatic plugs of different age
  Thrombosis Research, 1992
• Comparison of the haemorrhagic effects of unfractionated heparin and a low molecular weight heparin fraction (cy 216) in rabbits
  Thrombosis Research, 1986
• Evaluation of an amidolytic heparin assay method: Increased sensitivity by adding purified antithrombin III
  Thrombosis Research, 1977
• The Control of Dicumarol Therapy and the Quantitative Determination of Prothrombin and Proconvertin
  Scandinavian Journal of Clinical and Laboratory Investigation, 1951